Showing results (11-20 of 354) with videos related to
Sort By:
Pageof 36
Transplantation|May 27, 1997
Localization of cryptic tolerogenic epitopes in the alpha1-helical region of the RT1.Au alloantigenM Wang, S M Stepkowski, J Yu, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1994
Rapamycin inhibits production of cytotoxic but not noncytotoxic antibodies and preferentially activates T helper 2 cells that mediate long-term survival of heart allografts in ratsM Ferraresso, L Tian, R Ghobrial, et al.Clinical Biochemistry|March 1, 1997
Distribution of sirolimus in rat tissueK L Napoli, M E Wang, S M Stepkowski, et al.Transplantation|January 1, 1991
Synergistic interactions of cyclosporine and rapamycin to inhibit immune performances of normal human peripheral blood lymphocytes in vitroB D Kahan, S Gibbons, N Tejpal, et al.Transplantation|October 1, 1993
Immunosuppressive effects of defibrotideM Ferraresso, P Rigotti, S M Stepkowski, et al.Transplantation|February 15, 1996
Beneficial effect of graft perfusion with anti-T cell receptor monoclonal antibodies on survival of small bowel allografts in rat recipients treated with brequinar alone or in combination with cyclosporine and sirolimusM Wang, X Qu, S M Stepkowski, et al.Cell Transplantation|July 1, 1998
Intrasplenic liver parenchymal cells in conjunction with low-dose rapamycin and cyclosporine induce a unique and specific prolongation of rat cardiac and small bowel allograft survivalM J Boyle, V Baghdassarian, S M Stepkowski, et al.Annals of Transplantation|January 1, 1996
Kinetics of in vitro immune responses of T and B cells during tolerance induction by sirolimusR Ghobrial, M Karczewski, M Ferraresso, et al.Transplantation|February 1, 1992
Inhibition of host-versus-graft and graft-versus-host responses after small bowel transplantation in rats by rapamycinS M Stepkowski, H F Chen, M E Wang, et al.Transplantation|November 1, 1991
In vitro correlates of in vivo therapy with cyclosporine to immunosuppress rejection of heterotopic rat cardiac allografts across strong (RT-1) plus weak (non-RT-1) histocompatibility differencesS Miyagawa, S M Stepkowski, J G Lawen, et al.Pageof 36